ADMA

MKT CAP:$2B

ADMA Biologics Inc

Market Cap

$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$8.06-$9.82 (-54.92%)

Jun 8, 2026

52W High $21.8752W Low $7.60

Company Details

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company...

CEO

—

IPO Date

Oct 17, 2013

Website

www.admabiologics.com

Key Metrics TTM

Revenue

$510M

+11.0% YoY

Net Income

$165M

EPS (Diluted)

Free Cash Flow

$108M

Revenue / Share

$2.12

Gross Margin

61.3%

Operating Margin

40.6%

Net Margin

32.4%

FCF Margin

21.2%

P/S

3.6x

P/E

11.2x

Earnings Reports

Q1 2026

May 6, 2026

$114M-0.3%

FY 2025

Feb 25, 2026

$510M+19.6%

Q4 2025

Feb 25, 2026

$139M+18.4%

Q3 2025

Nov 5, 2025

$134M+12.0%

Q2 2025

Aug 6, 2025

$122M+13.8%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee